Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 74 record(s)

Req # A-2021-000835

Adverse Drug Reaction (ADR) for SULFASALAZINE. Report number: E2B_03278682.

Organization: Health Canada

26 page(s)
December 2021

Req # A-2021-000925

Adverse Drug Reaction (ADR) METFORMIN HYDROCHLORIDE (Glucophage). Report number: E2B_03334949.

Organization: Health Canada

34 page(s)
December 2021

Req # A-2021-000992

Adverse Drug Reaction (ADR) for ANTI-THYMOCYTE GLOBULIN (RABBIT). Report number: E2B_03730412.

Organization: Health Canada

23 page(s)
December 2021

Req # A-2021-001025

Adverse Drug Reaction (ADR) for IRBESARTAN. Report number: E2B_03841049.

Organization: Health Canada

42 page(s)
December 2021

Req # A-2021-001033

Adverse Drug Reaction (ADR) for BISACODYL. Report number: E2B_03838805.

Organization: Health Canada

55 page(s)
December 2021

Req # A-2021-001037

Adverse Drug Reaction (ADR). Report number: E2B_04198371.

Organization: Health Canada

29 page(s)
December 2021

Req # A-2021-001048

Adverse Drug Reaction (ADR) for TRIAMCINOLONE ACETONIDE. Report number: E2B_03676035.

Organization: Health Canada

255 page(s)
December 2021

Req # A-2021-001102

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-114800-669, Letter to the COVID-19 Exposure Notification App Advisory Council Members.

Organization: Health Canada

12 page(s)
December 2021

Req # A-2021-001104

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-115452-86, Deputy Ministers’ Cyber Security Committee.

Organization: Health Canada

2 page(s)
December 2021

Req # A-2021-001162

Adverse Drug Reaction (ADR) for FUROSEMIDE. Report number: E2B_03879484.

Organization: Health Canada

22 page(s)
December 2021
Date modified: